🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this research study is to determine the maximum tolerab...
Status
Active Not Recruiting
Location
University of Rochester
Start Date
2020-11-23
Trial ID
NCT04477343
Treatments Being Tested
The goal of this clinical trial is to study the combination of SX-682 plus ...
Status
Recruiting
Location
University of California, Los Angeles
Start Date
2024-11-18
Trial ID
NCT06228053
Treatments Being Tested
ASpiRE will investigate the effect of the drug SX-682 in combination with A...
Status
Recruiting
Location
Oncology Institute of Southern Switzerland
Start Date
2025-04-28
Trial ID
NCT07002320
Treatments Being Tested
This study is a companion to the SYNERGY-201 clinical trial (NCT06228053), ...
Status
Recruiting
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2025-08-07
Trial ID
NCT07050433
Treatments Being Tested
Cancers attract myeloid-derived suppressor cells (MDSCs) that prevent our o...
Status
Active Not Recruiting
Location
University of Miami
Start Date
2019-06-12
Trial ID
NCT03161431
Treatments Being Tested
Background: Head and neck cancers (HNCs) account for about 5% of all cance...
Status
Not Yet Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2026-09-02
Trial ID
NCT07667400
Background: Combination immunotherapy techniques are being explored to imp...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2020-11-24
Trial ID
NCT04574583
Treatments Being Tested
The purpose of this study is to evaluate the safety and clinical activity o...
Status
Active Not Recruiting
Location
Johns Hopkins SKCCC
Start Date
2023-11-08
Trial ID
NCT05604560
Treatments Being Tested
This study will determine the safety profile, maximum tolerated dose (MTD),...
Status
Recruiting
Location
Mayo Clinic
Start Date
2020-06-30
Trial ID
NCT04245397
Treatments Being Tested
This phase II trial tests how well SX-682 and atezolizumab works for the tr...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-10-01
Trial ID
NCT07322341